Clarivate PLC officer Bar Veinstein filed a Form 144 notice on November 18, 2026, disclosing a proposed sale of 254,558 common shares of Clarivate PLC on the New York Stock Exchange.

Key Highlights

  • Filer and role: Bar Veinstein, identified as an officer of Clarivate PLC, filed the notice.
  • Shares proposed for sale: 254,558 common shares, with an aggregate market value of $542,284.91 as stated in the filing.
  • Source of shares: The securities were acquired as restricted stock from the issuer, with an acquisition date of March 1, 2026, upon vesting during the period March 1, 2026 through May 1, 2026, according to the filing's remarks.
  • Approximate sale date: November 18, 2026, to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services.
  • 10b5-1 plan: The filing indicates a plan adoption or instruction date of August 7, 2026, under Rule 10b5-1.
  • Shares outstanding: 639,904,301 common shares of Clarivate PLC were listed as outstanding at the time of the notice.
  • Prior sales: The filing reports nothing to report for securities sold during the past three months.

Veinstein's Proposed Rule 144 Sale of Clarivate Common Stock

Bar Veinstein, an officer of Clarivate PLC (NYSE:CLVT), submitted a Form 144 notice of proposed sale of securities to the U.S. Securities and Exchange Commission on November 18, 2026. The notice covers 254,558 shares of Clarivate common stock, with an aggregate market value stated in the filing as $542,284.91. The proposed sale is to be carried out on the New York Stock Exchange through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

According to the filing, the shares to be sold were originally acquired as restricted stock directly from the issuer on March 1, 2026. The filing's remarks section states that "the securities to be sold were acquired upon the vesting of restricted stock during the period of 3/1/2026 through 5/1/2026." No cash consideration was involved in the acquisition, and the filing notes the nature of payment as "Not Applicable." The filing also discloses that Veinstein adopted a written trading plan or gave trading instructions under Rule 10b5-1 on August 7, 2026.

The filing reports no sales of Clarivate securities by Veinstein during the three months preceding the notice date. With 639,904,301 common shares reported as outstanding, the proposed sale represents a portion of Veinstein's restricted stock holdings that vested in early 2026. Clarivate PLC is headquartered at 70 St. Mary Axe, London, United Kingdom.

What Was Disclosed

Clarivate PLC officer Bar Veinstein filed a Form 144 disclosing a proposed sale of 254,558 common shares valued at $542,284.91, acquired through restricted stock vesting, with a planned sale date of November 18, 2026, under a Rule 10b5-1 plan adopted August 7, 2026.